Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
19 people get TLCR articles and Market Currents by email alert.
Get email alerts on TLCR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
13 High-Volume, Rallying Stocks Being Snapped Up by the Smart MoneyKapitall • Mon, May 16, 2011 -
-
-
-
-
Nine Oversold Stocks With Bullish Options SentimentKapitall • Tue, Nov 16, 2010
-
Monday Options Update: F, ALU, WMB, TLCR, PG & LNGInteractive Brokers • Mon, Nov 15, 2010 -
Monday Options Brief: WMB, TLCR, PG & LNGInteractive Brokers • Mon, Nov 15, 2010
-
Merger Arbitrage Mondays: November 15, 2010Asif Suria • Mon, Nov 15, 2010
-
-
-
-
6 Overbought Stocks Reporting Earnings on July 29Kapitall • Thu, Jul 29, 2010
-
Kamada: Wise Strategy or Overly Ambitious?EP Vantage • Mon, Jul 12, 2010 -
Merger Arbitrage Mondays: June 14, 2010Asif Suria • Mon, Jun 14, 2010
-
Grifols' Talecris Package Leads a Hot Week for Life Sciences DealsThe Burrill Report • Sun, Jun 13, 2010 -
Grifols Gets a Taste for Talecris BloodThe Burrill Report • Thu, Jun 10, 2010
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
13 High-Volume, Rallying Stocks Being Snapped Up by the Smart MoneyKapitall • Mon, May 16, 2011
-
-
-
-
-
Nine Oversold Stocks With Bullish Options SentimentKapitall • Tue, Nov 16, 2010
-
Monday Options Update: F, ALU, WMB, TLCR, PG & LNGInteractive Brokers • Mon, Nov 15, 2010
-
Monday Options Brief: WMB, TLCR, PG & LNGInteractive Brokers • Mon, Nov 15, 2010
-
Merger Arbitrage Mondays: November 15, 2010Asif Suria • Mon, Nov 15, 2010
-
-
-
-
6 Overbought Stocks Reporting Earnings on July 29Kapitall • Thu, Jul 29, 2010
-
Kamada: Wise Strategy or Overly Ambitious?EP Vantage • Mon, Jul 12, 2010
-
Merger Arbitrage Mondays: June 14, 2010Asif Suria • Mon, Jun 14, 2010
-
Grifols' Talecris Package Leads a Hot Week for Life Sciences DealsThe Burrill Report • Sun, Jun 13, 2010
-
Grifols Gets a Taste for Talecris BloodThe Burrill Report • Thu, Jun 10, 2010
There are no Transcripts on TLCR.
-
at CNBC.com (Feb 8, 2011)
-
at MarketWatch.com (Jun 7, 2010)
-
at MarketWatch.com (Jun 7, 2010)
-
at MarketWatch.com (Jun 7, 2010)
-
at MarketWatch.com (Jun 7, 2010)
TLCR vs. ETF Alternatives
Company Description
We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapies that extend and enhance the lives of people suffering from chronic and acute, often life-threatening,... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
-
Monday, May 2, 2011, 9:00 AM
Premarket gainers: ICO +31%. TIVO +15%. TGE +12%. ZSL +11%. STEM +8%. LOCM +8%. SPPI +8%. CTIC +7%. DRL +7%. CEPH +5%. HRBN +5%. TLCR +5%. MOVE +4%. PCX +4%. TEVA +4%. AEZS +3%. MPEL +3%. NFLX +3%. CPST +4%.
Losers: AGQ -12%. VRX -9%. GPL -7%. THC -6%. EXK -6%. SLV -6%. SIVR -6%. AG -5%. SLW -5%. GRS -4%. SVM -3%. SIFY -4%. HL -3%. ACI -3%. PAAS -3%. Comment! [On the Move] - Wednesday, April 27, 2011, 4:59 PM Talecris Biotherapeutics (TLCR): Q1 EPS of $0.45 beats by $0.03. Revenue of $407M (+7% Y/Y) misses by $3M. (PR) Comment! [Earnings, Healthcare]
- Wednesday, April 27, 2011, 12:10 AM Notable earnings after Wednesday's close: AFL, AKAM, ALL, ARRS, BDN, BIDU, CCI, CDNS, COG, CTXS, CYH, DDR, DRE, EBAY, EQIX, EQR, EXXI, FLEX, FTNT, GMCR, ICO, IDCC, ISIL, LNC, LOGI, LSI, NKTR, NSC, NVLS, OI, ORLY, PMTC, QGEN, SBUX, SCI, TER, TLCR, TQNT, VAR, WLL,XLNX. Comment! [Earnings]
- Wednesday, February 23, 2011, 5:05 PM Talecris Biotherapeutics (TLCR): Q4 EPS of $0.38 in-line. Revenue of $411M (+5.3% Y/Y) in-line. Shares -0.3% AH. (PR) Comment! [Earnings]
- Wednesday, February 23, 2011, 12:10 AM Notable earnings after Wednesday's close: AUY, AVGO, GSS, HLX, HT, IDCC, LTD, RIG, TLCR, TS, XCO Comment! [Earnings]
-
Tuesday, November 2, 2010, 9:20 AM
Premarket gainers: ARTG +47%. BPI +15%. RDN +10%. MPEL +9%. NVMI +7%. PLG +7%. TSEM +5%. ABK +4%. LGND +4%. NBG +4%. MT +4%. MA +4%.
Losers: MSPD -17%. MVIS -10%. ENR -9%. ESLR -8%. PCBC -8%. TRS -7%. CLX -7%. TLCR -5%. HK -5%. ADM -5%. SWI -4%. TLK -4%. Comment! - Thursday, October 28, 2010, 10:00 AM Talecris Biotherapeutics (TLCR): Q3 EPS of $0.48 beats by $0.11. Revenue of $407M (+2.9%) vs. $411M. (PR) Comment!
- Tuesday, August 17, 2010, 10:36 AM Hedge fund manager John Paulson discloses portfolio updates: a new 66.7M share position in Popular (BPOP), a new 43.7M stake in American Capital (ACAS); new 5M-10M positions in ME, GGP, BEE, PMI, SY, TLCR and MNI; plus large additions in HIG and MYL. (largest holdings) 3 Comments
- Thursday, July 29, 2010, 9:26 AM Talecris Biotherapeutics (TLCR): Q2 EPS of $0.37 in-line. Revenue of $403M (+7.2%) vs. $399.8M. (PR) Comment!
- Thursday, July 29, 2010, 12:05 AM Notable earnings before Thursday's open: ABX, ADP, AVP, BC, BDX, BEN, BG, BLL, CE, CELG, CL, CLI, CNX, COV, CRI, DPS, EGO, EQT, GR, GT, GTI, HP, IPG, IRM, K, KBR, LIFE, LINE, LUV, MCO, MJN, MOT, NBL, NIHD, NOC, NOV, PDE, POT, PTEN, RDS.A, RSH, RTN, SBH, SNE, SU, TEN, TLCR, TRI, TSM, TYC, VTR, WM, WMB, WYNN, XEL, XOM, XRAY Comment!
- Monday, June 7, 2010, 9:15 AM Market Preview: Futures cling to early gains, with benchmark S&P +0.1% despite macro concerns weighing on overseas markets. Bank stocks are doing well after the G-20 gave up on a global bank levy, and [[Talecris]] has rocketed on news of its acquisition. Later today: Employment Trends, and a speech from Bernanke (calendar). Comment!
-
Monday, June 7, 2010, 9:00 AM
Premarket gainers: KRY +52%. TLCR +46%. IRE +8%. BPAX +8%. CTIC +7%. BMY +7%. EGLE +4%. VVUS +4%. S +4%.
Losers: DCTH -10%. OTE -7%. CVS -4%. Comment! - Monday, June 7, 2010, 7:22 AM Spanish healthcare company Grifols buys Talecris (TLCR +38.4%) for $4B including debt. The acquisition is good news for Cerberus, which holds a significant stake in Talecris and previously tried to sell the company. (PR) Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.